Boothbay Fund Management, LLC Chembio Diagnostics, Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $65,756 - $128,772	-22,832 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.11 - $7.51 $93,839 - $171,468	22,832 New	22,832 $108,000
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $153,323 - $277,197	-46,745 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.18 - $15.54 $85,507 - $417,855	-26,889 Reduced 36.52%	46,745 $152,000
Q1 2020 May 15, 2020	SELL	$2.36 - $5.6 $115,231 - $273,431	-48,827 Reduced 39.87%	73,634 $377,000
Q4 2019 Feb 14, 2020	BUY	$3.94 - $5.76 $36,291 - $53,055	9,211 Added 8.13%	122,461 $558,000
Q3 2019 Nov 14, 2019	BUY	$4.84 - $7.25 $103,295 - $154,729	21,342 Added 23.22%	113,250 $693,000
Q2 2019 Aug 14, 2019	BUY	$5.56 - $7.85 $139,606 - $197,105	25,109 Added 37.59%	91,908 $560,000
Q1 2019 May 15, 2019	BUY	$5.32 - $7.18 $185,928 - $250,933	34,949 Added 109.73%	66,799 $371,000
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $157,657 - $334,425	31,850 New	31,850 $180,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.